Clinical Trial: Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658378) titled 'Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.' on June 13.

Brief Summary: A randomozed control trial on adults who underwent CABG surgery. To evaluate the effectiveness of intraoperative continuous infusion (CI) of cefazolin compared with intermittent (INT) cefazolin administration in preventing SSIs in a CABG (coronary artery bypass grafting) population.

Eligible patients will be randomized using block randomization into 2 groups: intervention group and control group. The intervention group will use continuous infusion of cefazolin (...